Highland Long/Short Healthcare Fund Class C (HHCCX)

11.16
Net Asset Value
-1.06%
1 Day
-2.28%
Year-to-Date
Overall Morningstar Rating
Long-short equity
Style or Category
No Load
Sales Expenses
3.45%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks to achieve its investment objective by investing at least 80% of the value of its total assets (net assets plus any borrowings for investment purposes) under normal circumstances in securities of companies principally engaged in the design- development- production- sale- management or distribution of products- services or facilities used for or in connection with healthcare or medicine ("healthcare companies"). It is non-diversified.

Performance

1 month+1.90% 3 years-8.68%
3 months-2.76% 5 years+3.76%
1 year+9.83% Since inception+3.99%
Data through --

Peer Comparisonvs. Long-short equity

 HHCCXCategory
Performance 5-yr return+3.76%+4.49%
Expense ratio3.45%1.89%
Risk 5 year sharpe ratio0.300.57
Net assets$69.5M$338.1M
Average market cap$3.8B$39.0B
Average P/E--18.1
Portfolio turnover964%964%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHighland Funds
Fund manager & tenureAndrew Hilgenbrink / 0 Years
Minimal initial investment$2,500.00
Minimum IRA investment$50.00

Holdings

U.S. stock72.77%
International stock26.67%
Fixed income0.57%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 94.68%
Hardware 2.03%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
-- 15.56%
HUM Humana Inc15.46%
XBI SPDR® S&P Biotech ETF14.16%
NERV Minerva Neurosciences Inc11.71%
SHPG Shire11.58%
ANTM WellPoint10.94%
AMRN Amarin Corporation PLC9.16%
QHC Quorum Health Corp8.51%
LHCG LHC Group Inc8.18%
-- 7.68%